Fluor Corporation (NYSE: FLR) announced today that it is currently performing early construction management services for Baxter International Inc.’s new biotechnology facility near Covington, Georgia, about 45 miles southeast of Atlanta. Mass excavation and earth works are underway at the project site. Fluor previously booked its share of the project value in the third quarter of 2012. “Fluor is proud that our project and construction management services will help Baxter make this facility a reality to create therapies to treat a number of chronic and acute conditions, including immune deficiencies and critical care patients around the world,” said Steve Dobbs, president of Fluor’s Industrial & Infrastructure Business Group. Commercial production at Baxter’s new facility is scheduled to begin in 2018. The Covington site will have the flexibility and necessary infrastructure to expand further to support additional global market needs. Fluor’s Greenville, S.C. office will provide support to the onsite construction management team. The construction labor workforce is expected to total about 2,200 at construction peak. About Fluor Corporation For more than 100 years, Fluor Corporation (NYSE: FLR) has partnered with its clients to design, build and maintain many of the world's most challenging and complex capital projects. Through its global network of offices on six continents, Fluor's 43,000 employees provide comprehensive capabilities and world-class expertise in the fields of engineering, procurement, construction, commissioning, fabrication, operations, maintenance and project management. Today, the company serves a global client base in the energy, chemicals, government, industrial, infrastructure, operations & maintenance, manufacturing & life sciences, mining, power and transportation sectors. Headquartered in Irving, Texas, Fluor ranks 124 on the FORTUNE 500 list and had revenue of $24.3 billion in 2011. For more information, visit www.fluor.com.